Showing 1 - 4 results of 4 for search 'Arash Jahangiri', query time: 0.02s Refine Results
  1. 1
    Utilizing B-Spline Curves and Neural Networks for Vehicle Trajectory Prediction in an Inverse Reinforcement Learning Framework

    Utilizing B-Spline Curves and Neural Networks for Vehicle Trajectory Prediction in an Inverse Reinforcement Learning Framework by Mohammad Sadegh Jazayeri, Arash Jahangiri

    Published 2022-02-01
    Get full text
    Article
  2. 2
    Deep Learning Architectures for Skateboarder–Pedestrian Surrogate Safety Measures

    Deep Learning Architectures for Skateboarder–Pedestrian Surrogate Safety Measures by Chowdhury Erfan Shourov, Mahasweta Sarkar, Arash Jahangiri, Christopher Paolini

    Published 2021-09-01
    Get full text
    Article
  3. 3
    Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years

    Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years by Fatemeh Gholami, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, Mohammadreza Ahi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Akram Ansarifar, Pouria Basiri, Milad Moradi, Arash Jahangiri, Kosar Naderi, Soheil Ghasemi, Pezhman Khatami, Mohsen Honari, Samane Khodaverdloo, Mohammad Shooshtari, Hajar Mehr Azin, Sohrab Moradi, Batool Shafaghi, Hossein Allahyari, Arina Monazah, Ali Khodaei Poor, Zahra Taghva, Hooman Bakhshande, Mohammad Karimi Nia, Masoud Solaymani Dodaran, Mohsen Forooghizade

    Published 2023-02-01
    Get full text
    Article
  4. 4
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial

    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial... by Akram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, Mohammadreza Ahi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fatemeh Gholami, Pouria Basiri, Milad Moradi, Arash Jahangiri, Kosar Naderi, Soheil Ghasemi, Pezhman Khatami, Mohsen Honari, Samane Khodaverdloo, Mohammad Shooshtari, Hajar Mehr Azin, Sohrab Moradi, Batool Shafaghi, Hossein Allahyari, Arina Monazah, Ali Khodaei Poor, Hooman Bakhshande, Zahra Taghva, Mohammad Karimi Nia, Masoud Solaymani Dodaran, Mohsen Foroughizadeh

    Published 2023-12-01
    Get full text
    Article

Search Tools: